MedTrace Logo

ECMO Braile Biomédica® in COVID-19 Patients

NCT06086405 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 30

Last updated 2023-10-17

No results posted yet for this study

Summary

Retrospective data collection to evaluate the gas transfer capacity of the Braile Biomédica® OxyPrime® ECMO BRCoating® Membrane Oxygenator in COVID-19 patients during the pandemic.

Conditions

Interventions

DEVICE

Patients underwent cardiorespiratory support

Patients underwent cardiorespiratory support using the Oxyprime® ECMO Braile Biomédica® Membrane Oxygenator

Sponsors & Collaborators

  • Braile Biomedica Ind. Com. e Repr. Ltda.

    lead INDUSTRY

Principal Investigators

  • Vitor S Barzila · Hospital Brasília

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-09-14
Primary Completion
2024-01-31
Completion
2024-03-31

Countries

  • Brazil

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06086405 on ClinicalTrials.gov